… represents a missed opportunity to lower BP and CVD risk. In conjunction with previous
evidence, 4–6 the current analysis suggests that to restore an upward trend in BP control rates, …

… We report results comparing monotherapy drug classes from participating data sources … As
expected, we saw blunted estimates of differential effectiveness and risks between drug class …

… of antihypertensive drugs initiated as a two-drug combination versus monotherapy on BP
control and cardiovascular risk. … identified in primary care or through hospital admission.35 …

… Treatment guidelines focus on individual risk factors like … health care organizations as
data sources stay anonymous. … mild hypertension due to the requirement of a monotherapy. …

… This study identified signals for most well-known adverse events of antihypertensives, such
as increased risk for bradycardia in β-blockers, angioedema or cough in ACE inhibitors, and …

… The antihypertensive drugs prescribed in monotherapy … ) according to the hospital admission
and the drugs prescribed in … , the chance of being highly adherent to antihypertensive drug …

… prescription of monotherapy or 2 antihypertensive drugs (B, … antihypertensive drug treatment,
the risk of hospitalization for hip … for a number of drug classes compared randomly selected …

… a prescription for an antihypertensive drug outside their monotherapy class. Patients were
… Monotherapy with major antihypertensive drug classes and risk of hospital admissions for …

… with hypertension, few studies have investigated the application … a first-line antihypertensive
drug in monotherapy before and after … . Persistence, adherence, and risk of discontinuation …

… Antihypertensive agent exposure has been identified in EHRs at admission of the hospital
stay for … exposure to the most frequent antihypertensive regimens, including monotherapies. …